Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Birth Defects Res A Clin Mol Teratol. 2011 Aug 24;91(10):879–884. doi: 10.1002/bdra.22849

Table 3.

Summary of Log-Linear Modeling Results for the Combined CTD and LSL Case-Parents Triads.

MTHFR A1298C (1801131)a
481/168/20b
MTHFR C677T (1801133)
487/165/18
MTRR A66G (1801394)
461/183/25
MCP1 A2518G (1024611)
477/172/19
BHMT G742A (3733890)
481/172/17
TCN2 C777G (1801198)
473/165/30
SHMT C1420T (1979277)
479/172/18
NOS3 G894T (179983)
469/179/19
R1c (95% CI) 0.84 (0.68–1.04) 1.22 (0.98–1.52) 0.84 (0.64–1.09) 1.02 (0.82–1.27) 0.96 (0.77–1.19) 0.77 (0.62–0.97) 1.12 (0.9–1.4) 1.03 (0.83–1.29)
R2 (95% CI) 0.91 (0.63–1.33) 1.17 (0.82–1.66) 0.79 (0.56–1.09) 1.05 (0.68–1.61) 0.86 (0.58–1.28) 0.73 (0.52–1.02) 1.22 (0.83–1.79) 0.96 (0.65–1.41)
S1d (95% CI) 1.04 (0.82–1.31) 1.15 (0.90–1.47) 1.23 (0.90–1.69) 0.99 (0.78–1.27) 0.81 (0.64–1.04) 1.17 (0.91–1.51) 0.84 (0.66–1.08) 1.26 (0.98–1.63)
S2 (95% CI) 0.83 (0.55–1.27) 1.46 (1.01–2.12) 1.17 (0.84–1.64) 0.89 (0.55–1.44) 0.84 (0.55–1.28) 0.99 (0.71–1.37) 0.67 (0.43–1.05) 1.43 (0.94–2.20)
LRT for offspring effects (p-value) 2.59 (0.27) 3.23 (0.20) 2.24 (0.33) 0.05 (0.97) 0.56 (0.76) 5.35 (0.07) 1.43 (0.49) 0.23 (0.89)
LRT for maternal effects (p-value) 0.97 (0.61) 4.34 (0.11) 1.66 (0.44) 0.23 (0.89) 2.97 (0.23) 1.92 (0.38) 3.99 (0.14) 4.77 (0.09)
a

dbSNP rs#

b

Number of triads with genotype data for 3, 2 or 1 member.

c

R1 and R2 denote the relative risk to cases with the heterozygous and rare homozygous genotypes, respectively, as compared to cases with the common homozygous genotype.

d

S1 and S2 denote the relative risk to offspring of women with the heterozygous and rare homozygous genotypes, respectively, as compared to the common homozygous genotype.